Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to GIST
Related studies linked through entity extraction aliases.
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor
- Status
- COMPLETED
- Phase
- N/A
Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST
- Status
- COMPLETED
- Phase
- N/A
11C-Acetate PET/CT Non-FDG-Avid Tumors
- Status
- UNKNOWN
- Phase
- N/A
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
- Status
- COMPLETED
- Phase
- PHASE2
Perifosine + Sunitinib Malate for Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1